Literature DB >> 22317767

Polymorphisms in the IL-13 and IL-4R genes are associated with the development of renal cell carcinoma.

H Chu1, M Wang, F Yan, D Zhong, D Shi, L Ma, X Pan, C Qin, C Yin, Z Zhang.   

Abstract

BACKGROUND: Cytokines are the important modulators that bind to their relevant receptors in response to some stimuli to mediate the homeostasis. It has been suggested that the imbalance of immune system of the host might affect the generation of diseases, including cancers. PATIENTS AND METHODS: We investigated the association between six functional polymorphisms of IL-4, IL-13, and IL-4R genes and susceptibility to renal cell cancer in a hospital-based study, including 620 renal cell carcinoma (RCC) patients and 623 controls. Logistic regression model was used to assess the genetic effects on the development of RCC.
RESULTS: Overall, individuals with IL-4R Ile50Val CT/TT genotypes had a 0.34-fold significantly decreased RCC risk (CT/TT versus CC), and the T variant allele was associated with a decreased risk of RCC in a dose-response manner (Ptrend=0.009). In addition, we also observed that IL-13 C-1055T and Arg130Gln polymorphisms could decrease the risk of RCC [TT versus CC/CT: odds ratio=0.36, 95% confidence interval (CI)=0.16-0.78; AA versus GG/GA: 0.66, 0.44-0.97, respectively]. Furthermore, a multiplicative interaction association between the combined IL-4R Ile50Val and IL-13 C-1055T genotypes was observed to decrease the risk of RCC (P=0.036).
CONCLUSION: IL-13 and IL-4R may play an important role in the etiology of RCC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22317767     DOI: 10.1093/annonc/mdr607

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  11 in total

1.  Genetic polymorphisms as predictive biomarker of survival in patients with gastrointestinal stromal tumors treated with sunitinib.

Authors:  J S L Kloth; M C Verboom; J J Swen; T van der Straaten; S Sleijfer; A K L Reyners; N Steeghs; H Gelderblom; H J Guchelaar; R H J Mathijssen
Journal:  Pharmacogenomics J       Date:  2017-01-24       Impact factor: 3.550

2.  The -590C/T polymorphism in the IL-4 gene and the risk of cancer: a meta-analysis.

Authors:  Jie Zhang; Danli Xie; Huaibin Zhou; Runping Fan; Longyi Zhang; Cixiu Li; Sheng Jin; Qinghe Meng; Jianxin Lu
Journal:  Tumour Biol       Date:  2013-04-11

3.  Associations between polymorphisms in the IL-4 and IL-4 receptor genes and urinary carcinomas: a meta-analysis.

Authors:  Yun Luo; Zhiqiang Ye; Ke Li; Ruihan Chen; Shigeng Li; Jun Pang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

4.  Associations of common IL-4 gene polymorphisms with cancer risk: A meta-analysis.

Authors:  Yingxian Jia; Xiaochuan Xie; Xiaohan Shi; Shangwei Li
Journal:  Mol Med Rep       Date:  2017-06-20       Impact factor: 2.952

5.  Polymorphism of the IL13 gene may be associated with Uterine leiomyomas in Slovenian women.

Authors:  J Krsteski; S Jurgec; M Pakiž; I But; U Potočnik
Journal:  Balkan J Med Genet       Date:  2017-03-08       Impact factor: 0.519

6.  Effects of IL-4-590C/T (rs2243250) Polymorphism on the Susceptibility of Smoking-Related Cancer: A Meta-Analysis Involving 11,407 Subjects.

Authors:  Guangyuan Chen; Cong Hu; Yuxuan Song; Haifei Zhang; Song Li; Penghui Lai; Yiling Zhang; Peng Huang
Journal:  Biomed Res Int       Date:  2019-12-02       Impact factor: 3.411

7.  Impact of single nucleotide polymorphism in IL-4, IL-4R genes and systemic concentration of IL-4 on the incidence of glioma in Iraqi patients.

Authors:  Haidar A Shamran; Subah J Hamza; Nahi Y Yaseen; Ahmad A Al-Juboory; Dennis D Taub; Robert L Price; Mitzi Nagarkatti; Prakash S Nagarkatti; Udai P Singh
Journal:  Int J Med Sci       Date:  2014-08-22       Impact factor: 3.738

8.  IL-13 receptor α2 is a negative prognostic factor in human lung cancer and stimulates lung cancer growth in mice.

Authors:  Mian Xie; Xiao-jun Wu; Jin-jun Zhang; Chao-sheng He
Journal:  Oncotarget       Date:  2015-10-20

9.  Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma.

Authors:  Meta H M Diekstra; Xiaoyan Liu; Jesse J Swen; Epie Boven; Daniel Castellano; Hans Gelderblom; Ron H J Mathijssen; Cristina Rodríguez-Antona; Jesus García-Donas; Brian I Rini; Henk-Jan Guchelaar
Journal:  Eur J Clin Pharmacol       Date:  2015-09-21       Impact factor: 2.953

10.  Identifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancers.

Authors:  Andrea Polo; Silvia Marchese; Giuseppina De Petro; Maurizio Montella; Gennaro Ciliberto; Alfredo Budillon; Susan Costantini
Journal:  Sci Rep       Date:  2018-07-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.